Settlement reached on access to Ivermectin
The SA Health Products Regulatory Authority (Sahpra) and various parties fighting for the use of Ivermectin to treat Covid-19 have reached a settlement on access to the drug, notes a News24 report.
In an order agreed by all parties and granted yesterday, the Gauteng High Court (Pretoria) ruled a registered pharmacist or medical practitioner might compound and sell compounded medicine that contained Ivermectin as an active ingredient.
‘Registered medical practitioners who are entitled to prescribe medicines in schedule 3 of the Act, may, in their professional discretion, prescribe Ivermectin to be compounded into a medicine that contains Ivermectin as an active ingredient for the treatment of their patients, on condition that the medicine is compounded by the holder of a licence,’ the order read.
The Sahpra and Minister of Health, who is listed as a respondent in the matter, were also ordered to pay more R1m to contribute to the costs of the four applicant groups.
‘We are very glad that the settlement was made an order of the court as this provides certainty for doctors and patients,’ said Dr George Coetzee, who was one of the applicants.
Lobby group AfriForum, also one of the applicants, welcomed the order.
‘Access in accordance with section 14 of the Act practically means that doctors can prescribe Ivermectin on their own judgment… Patients can then use this prescription to buy Ivermectin from any pharmacy where compounded Ivermectin is available,’ said Barend Uys, the head of research at AfriForum.
Article disclaimer: While we have made every effort to ensure the accuracy of this article, it is not intended to provide final legal advice as facts and situations will differ from case to case, and therefore specific legal advice should be sought with a lawyer.